GL1X · GenesisL1 explorer

MolNFT v1 · #85815 · protein

Structure of L1196M,G1269A double mutant anaplastic lymphoma kinase in complex with crizotinib

4ANS · ALK tyrosine kinase receptor: “Structure of L1196M,G1269A double mutant anaplastic lymphoma kinase in complex with crizotinib”. X-ray diffraction, 1 ligand (VGH), 2 pockets (best druggability 0.63). MolNFT v1 #85815 on GenesisL1: 3D…

PDB
4ANS
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
VGH
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29343% helix, 14% strandQ9UM73

Ligands and binding sites

  • VGH · 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13700.630.7846VGH
2570.380.7913empty

Compared structures

  • 4ANS · Structure of L1196M,G1269A Double Mutant Anaplastic Lymphoma Kinase in Complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.